Your browser doesn't support javascript.
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine.
Waheed, Sadia; Bayas, Angel; Hindi, Fawzi; Rizvi, Zufe; Espinosa, Patricio S.
  • Waheed S; Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
  • Bayas A; Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
  • Hindi F; Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
  • Rizvi Z; Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
  • Espinosa PS; Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
Cureus ; 13(2): e13426, 2021 Feb 18.
Article in English | MEDLINE | ID: covidwho-1143809
ABSTRACT
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Vaccines Language: English Journal: Cureus Year: 2021 Document Type: Article Affiliation country: Cureus.13426

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Vaccines Language: English Journal: Cureus Year: 2021 Document Type: Article Affiliation country: Cureus.13426